SI Materials and Methods

Human skeletal muscle biopsies for the in vivo study
The volunteers of the in vivo study had neither history of sleep disorder as confirmed by prestudy questionnaires MCTQ (1), Horne-Ostberg (2) and PSQI (3) (see Tables S4-S6) , nor did they participate in a shifted work schedule, or travelled across more than two time zones within three weeks preceding the study. Each participant adhered to a consistent daily feeding and sleeping routine. Specifically, participants woke between 06:00 and 07:00 h and went to bed between 22:00 and 23:00 h (with individual wake-up and sleep times recorded during the week and verified via time-stamped voicemails) -resulting in an average of 8 h sleep opportunity. In addition, participants exposed themselves to 15 min natural light within 1.5 h of waking, as verified by wearable light sensors (ActiWatch™). Self-selected meals were scheduled at 08:00 h, 12:00 h and 18:00 h, with defined snacks at 10:00 h, 15:00 h and 20:00 h daily. Participants arrived in the laboratory at 19:00 h on the day prior to the testing day and ingested a standardized meal and snack (6405 kJ, 132 g carbohydrate, 76 g fat, 70 g protein) that first evening and remained for the duration of their stay in a semi-recumbent position.
The resting metabolic rate was measured via indirect calorimetry the next morning according to best practice and used to calculate individual energy requirements at rest, which were then precisely met on an individual basis by prescribing hourly ingestion during waking hours of a mixed-macronutrient meal-replacement solution (Resource, Nestlé, CH) containing 5270 kJ/L, 140 g/L carbohydrate, 35 g/L fat, 94 g/L protein in small volumes relative to metabolic requirements (i.e. 92 ± 17 ml) to ensure energy and nutrient balance. The laboratory was free from natural light and with artificial lighting standardized to 800 lux in the direction of gaze, ambient temperature maintained between 20-25°C (23.6 ± 3.62°C; mean ± SD) and noise levels tightly regulated. Participants were not permitted to sleep during waking hours when lights were on (07:00-22:00 h) and wore eye masks whilst trying to sleep during lights-out (22:00-07:00 h). Participants remained asleep during hourly blood sampling throughout the night but were woken briefly for acquisition of the nighttime muscle biopsy samples but without removing their eye masks. Anesthetic administration (1% lidocaine w/o epinephrine) and skin/fascia incisions for this procedure (4) were completed within the hour prior to sleep such that night-time samples could be acquired within several minutes from pre-prepared sites with minimal discomfort. Three samples were taken from each leg in alternating and ascending order (starting with the non/dominant limb counterbalanced between participants), with skin incisions separated by 2-3 cm.
Melatonin and cortisol analyses
Blood samples were drawn every hour, starting on the testing day throughout both the waking and sleeping periods. Samples were obtained using an intravenous cannula fitted to the antecubital vein. The first 2 ml was drawn and discarded as waste before a further 10 ml was extracted. Of this 10 ml, 2 ml was dispensed in to a centrifuge tube containing lithium heparin, 4 ml was allocated to a plain serum tube and the remaining 4 ml was deposited in a tube coated with EDTA. The lithium heparin and EDTA tubes were both immediately centrifuged for 10 minutes (3466 g, 4°C) after which the supernatants were removed and stored at -80°C. Melatonin was measured as previously described (5) and cortisol was measured by COBAS (Roche).
In vitro skeletal myotube synchronization and real-time bioluminescence recording
Myoblasts were transduced with a Bmal1 luciferase (Bmal1-luc) (6) containing lentiviral reporter with a multiplicity of infection (MOI) = 3, grown to confluence, and subsequently differentiated into myotubes, as previously described by us in (7). For lentiviral production see (8). To synchronize primary myotubes, 10 µM forskolin (Sigma) was added to the culture medium for 1 h, followed by a medium change. For bioluminescence recording the culture medium was changed to the phenol red-free recording medium containing 100 µM luciferin (D-luciferin 306-250, NanoLight Technology) and cells were transferred to a 37°C light-tight incubator (Prolume LTD), as previously described by us (8). Bioluminescence from each dish was continuously monitored using a Hamamatsu photomultiplier tube (PMT) detector assembly. Photon counts were integrated over 1 min intervals. Bioluminescence profiles are shown as detrended data. For detrended time series, luminescence signals were smoothened by a moving average with a window of 24 h. For this, each data point was divided by the average of data points in an interval of 24 h (12 h before and 12 h after the analyzed data point). (33% in absolute ethanol) were purchased from Sigma. Chloroform, methanol, n-butanol and ammonium molybdate were from Acros Organics. LC-MS grade methanol, water and ammonium acetate were from Fluka. HPLC grade chloroform was purchased from Acros Organics. Monopotassium phosphate and L-ascorbic acid were from Sigma. 70% perchloric acid was from Merck.
Materials for lipid extraction
Lipid extraction procedure
Lipid extracts were prepared using the MTBE protocol (9). Briefly, ~30 mg ground skeletal muscle tissue or human primary myotubes harvested from one confluent 10 cm dish (~1.5 x added to the dried lipid extract and then incubated at 53°C for 1 h in a water bath. Lipids were cooled to RT and then dried. For desalting, the dried lipid extract was resuspended in 300 µl water-saturated n-butanol and then extracted with 150 µl H 2 O. The organic phase was collected, and the aqueous phase was re-extracted twice with 300 µl water-saturated nbutanol. The organic phases were pooled and dried in a vacuum concentrator.
Determination of total phosphorus
100 µl of the total lipid extract, resuspended in chloroform/methanol (1:1), were placed into 13 mm disposable pyrex tubes and dried in a vacuum concentrator. 0, 2, 5, 10, 20 µl of a 3 mM KH 2 PO 4 standard solution were placed into separate pyrex tubes. To each tube 20 µl of water and 140 µl of 70% perchloric acid were added. Samples were heated at 180°C for 1 h in a chemical hood. Then, 800 µl of a freshly prepared solution of water, ammonium molybdate (100 mg/8 ml H 2 O) and ascorbic acid (100 mg/6 ml H 2 O) in a ratio of 5:2:1 (v/v/v) were added. Tubes were heated at 100°C for 5 min with a marble on each tube to prevent evaporation. Tubes were cooled at RT for 5 min. 100 µl of each sample was then transferred into a 96-well microplate and the absorbance at 820 nm was measured.
Phospho-and sphingolipid analysis by mass spectrometry
Mass spectrometry analysis for the identification and quantification of phospho-and 
Data analysis
The clustering of the circadian lipid data into two groups was computed with a custom made procedure in MATLAB as follows.
Step 1: the z scores were computed from raw lipid concentration data for each lipid/subject and after removal of outliers.
Step 2: for each subject/lipid/biological replicate, the z-scores were detrended with the mean over 6 (in vivo)
or 7 (in vitro) time points.
Step 3: for each subject/lipid, the phase and amplitude for period 22 h (in vitro) and 24 h (in vivo) of a sinusoidal fit was computed using ordinary least squares using the two biological replicates per time point. P values of the coefficients were computed assuming normality of the data.
Step 4: for clustering, the signals were retained if they had a p value of the fit with FDR less than 0.05 (in vitro) or 0.10 (in vivo) using the BenjaminiHochberg procedure applied over all lipids and subjects. The data were then clustered into two groups using k means in MATLAB (using 20 replicates).
Step 5: two different sinusoids with fixed periods 22 h (in vitro) and 24 h (in vivo) were fit using ordinary least squares through all the data respecting the earlier determined clustering. The clustering was encoded with a standard 0/1 categorical variable. P values on the coefficients of the fit were calculated assuming normality of the data and verified to be significant (≤ 0.05) for each fitted sinusoid.
Step 6: for visualizing the 95% confidence intervals of the fit, the standard errors on the coefficients were used in a Monte Carlo procedure to generate 500 fits.
Time-series for lipid data were analyzed by ARSER (12) 
Figure S7. Myosin isoform analysis. (A) RT-qPCR results for MYH1, MYH2, MYH4 and
MYH7 on mRNA samples extracted from human skeletal muscle biopsies derived from two different origins (vastus lateralis or gluteus maximus). For donor characteristics see Table S1 and S2. Data were normalized to GAPDH (mean ± SEM). (B) Myosin isoform expression levels relative to MYH1. Myotube cells of donors 1-10 were used for the in vitro lipidomic analysis. * cDNA of these donor biopsies was used for myosin isoform analysis. # Donors used for siRNA-mediated clock disruption experiment. 
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